Concepedia

Kannan Gunasekaran

KG

37

Publications

3.2K

Citations

27

H-Index

1996

Active since

Affiliations

Tel Aviv University(Current)

Science Applications International Corporation (United States)

Amgen (United States)

Frederick National Laboratory for Cancer Research

National Cancer Institute

Kannan Gunasekaran is an author at Tel Aviv University specializing in medicine, molecular biology, and protein folding.

ORCID

Top concepts

Publications per year

1996–2021

37

Publications

37

Extended disordered proteins: targeting function with less scaffold

Kannan Gunasekaran, Chung‐Jung Tsai, Sandeep Kumar et al. · Trends in Biochemical Sciences · 2003 · 336 citations

, , +6

Enhancing Antibody Fc Heterodimer Formation through Electrostatic Steering Effects

Kannan Gunasekaran, Martin Pentony, Min Shen et al. · Journal of Biological Chemistry · 2010 · 279 citations · Full text

, , +11

A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair

Mónica Florio, Kannan Gunasekaran, Marina Stolina et al. · Nature Communications · 2016 · 248 citations · Full text

Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic

Todd Logan, Matthew Simon, Gerald Maxwell Cherf et al. · Cell · 2021 · 210 citations · Full text

, , +11

Brain delivery and activity of a lysosomal enzyme using a blood-brain barrier transport vehicle in mice

Julie C. Ullman, Annie Arguello, Jennifer A. Getz et al. · Science Translational Medicine · 2020 · 194 citations

, , +15

Rows per page

1–5 of 37